// company-profile

Supernus Pharmaceuticals, Inc.

SUPN
ExchangeNasdaqSectorPharmaceutical PreparationsInc.DEFilings184Insiders13
// api This Supernus Pharmaceuticals, Inc. insider-trading data is served live by the Form4API insider trading API. Get the same data via API.

// activity-summary

No insider transactions in the last 30 days.

No insider activity recorded for SUPN in the last 90 days.

Institutional Ownership

Top 13F-HR holders of Supernus Pharmaceuticals, Inc. as of 2026-03-31

↑ increasing
Total reported AUM
$2.69B
QoQ change
+16.7%
Reporting period
2026-03-31
#1
BlackRock, Inc.
CIK 2012383
$317.9M
6.1M shares
#2
MILLENNIUM MANAGEMENT LLC
CIK 1273087
$171.4M
3.3M shares
#3
VANGUARD CAPITAL MANAGEMENT LLC
CIK 2100119
$127.5M
2.5M shares

Data source: SEC Form 13F-HR filings. Joined with insider activity above — see who's loading up institutionally while insiders are trading. Full 13F-HR API →

Insider Transactions

Sourced from SEC EDGAR Form 4 filings. Updated hourly.

DateInsiderCompanyTypeSharesPriceValue
Mar 18, 2026Bhatt Padmanabh P.SUPN
Option Exercise10b5
7,250$0.00$0K
Mar 18, 2026Bhatt Padmanabh P.SUPN
Sale10b5
412$50.48$21K
Mar 18, 2026Bhatt Padmanabh P.SUPN
Option Exercise10b5
7,250$39.40$286K
Mar 18, 2026Bhatt Padmanabh P.SUPN
Sale10b5
6,838$49.55$339K
Mar 17, 2026Bhatt Padmanabh P.SUPN
Option Exercise10b5
12,250$0.00$0K

45 more transactions hidden

Free account · No credit card required

Building something? Get API access →

Popular companies on Form4API

Browse insider trading activity for other actively-filed companies.